7
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Epinine Kinetics and Plasma Catecholamine Changes Following Oral Administration of the Prodrug Ibopamine in Patients with Chronic Heart Failure

, , &
Pages 3707-3718 | Received 09 Apr 1991, Accepted 31 May 1991, Published online: 23 Oct 2006
 

Abstract

Epinine plasma levels, and Epinine - induced plasma Catecholamine changes were investigated in nine patients with chronic heart failure (NYHA class I and II), following oral administration of Ibopamine 100 mg. Norepinephrine, Epinephrine, Dopamine, and Epinine plasma levels were monitored for up to four hours after the drug administration. Arterial pressure and heart rate were recorded, too. Epinine plasma levels were lower than previously estimated, the maximal individual level ranging from 2792 to 7228 pg/mL. Both Norepinephrine and Epinephrine showed a very small decrease (less than 18%) after Ibopamine administration. No changes were shown in arterial pressure and heart rate. Previous assessment of Epinine pharmacokinetics is likely to be reviewed extensively owing to possible overestimation by assay methods used in former studies. Epinine - induced plasma Catecholamine changes may be mediated by (i) the claimed hemodynamic effect of the drug, and/or (ii) by the complex interrelationships between Epinine itself and both adrenergic and dopaminergic receptors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.